Quote | SpringWorks Therapeutics Inc. (NYSE:SWTX)
Last: | $ |
---|---|
Change Percent: | 9.36% |
Open: | $30.72 |
Close: | $33.30 |
High: | $34.35 |
Low: | $29.41 |
Volume: | 169,218 |
Last Trade Date Time: | 02/12/2020 04:43:31 pm |
News | SpringWorks Therapeutics Inc. (NYSE:SWTX)
STAMFORD, Conn., July 01, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the Company has completed the submission of a New Drug Application (NDA) to the U.S. Food...
2024-06-27 14:14:36 ET Summary Top-line data from Part B of phase 3 RINGSIDE study, using AL102 for the treatment of patients with desmoid tumors, expected 2nd half of 2025. The global desmoid tumor market is projected to grow to $5.49 billion by 2032. IM-1021 is an antibody-d...
Message Board Posts | SpringWorks Therapeutics Inc. (NYSE:SWTX)
Subject | By | Source | When |
---|---|---|---|
10 years since last post on this board, | UKdude | investorshub | 05/24/2022 11:20:50 AM |
Solutia Commences Tender Offer to Acquire Southwall Technologies Inc. | BSWB | investorshub | 10/25/2011 4:21:31 PM |
Nice gap up | $King | investorshub | 10/09/2011 4:14:12 PM |
Solutia to Acquire Southwall Technologies Inc. | MWM | investorshub | 10/07/2011 12:58:06 PM |
It's a great thing they are on the | MWM | investorshub | 05/20/2011 1:58:03 PM |
News, Short Squeeze, Breakout and More Instantly...
SpringWorks Therapeutics Inc. Company Name:
SWTX Stock Symbol:
NYSE Market:
SpringWorks Therapeutics Inc. Website:
STAMFORD, Conn., July 01, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the Company has completed the submission of a New Drug Application (NDA) to the U.S. Food...
2024-06-24 22:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that management will participate in a fireside chat at the Goldman Sachs 45 th Annual Glob...